Smoking as a modifier of the systolic blood pressure-induced risk of cardiovascular events and mortality: A population-based prospective study of middle-aged men

Journal of Hypertension

Volumn 20, Issue 9, 2002, Pages 1759-1764

  Khalili, Payam ^a   Nilsson, Peter M ^a   Nilsson, Jan Åke ^a   Berglund, Göran ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hypetension; Morality; Screening; Smoking; Systolic blood pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; FOLLOW UP; HEALTH CARE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCREENING; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 0036734304     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200209000-00019     Document Type: Article

References (23)

1. Cardiovascular risk factors in treated hypertensives - A nationwide, cross-sectional study in Sweden
2. Morbidity and mortality in relation to blood pressure and antihypertensive treatment. A 12 year follow-up study of a population sample of Swedish women
3. Mortality and morbidity in relation to systolic blood pressure in two populations with different management of hypertension: The study of men born in 1913 and the multifactorial primary prevention trial
4. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension
5. High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. A retrospective study of 40-59-year-old hypertensives in a Swedish primary care district
6. Predictors of cardiovascular morbidity in treated hypertension: Results from the primary preventive trial in Göteborg, Sweden
7. Treatment of high blood pressure - The effect on coronary morbidity and mortality
8. Cardiovascular risk groups and mortality in an urban Swedish male population: The Malmö preventive project
9. Long-term outcome of the Maimö preventive project: Mortality and cardiovascular morbidity
10. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
11. Cardiovascular risk factors and their effects on the decision to treat hypertension: Evidence based review
12. Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project
13. Acute myocardial infarction in patients treated for hypertension in the Skaraborg Hypertension Project
14. The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: Further analyses of 12 years of follow-up of treated hypertensives in the primary prevention trial in Gothenburg, Sweden
15. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
16. Blood pressure as a cardiovascular risk factor: Prevention and treatment
17. Blood pressure and mortality during an up to 32-year follow-up
18. Does the relation of blood pressure to coronary heart disease risk change with aging?
19. Excess mortality associated with increased pulse pressure among middle-aged men and women is explained by high systolic blood pressure
20. Cardiovascular protection and blood pressure reduction: A meta-analysis
21. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
22. Joint British recommendations on prevention of coronary heart disease in clinical practice
23. 1999 WHO/ISH guidelines for the management of hypertension